Silicon Valley Bank Results Presentation Deck
Continued momentum from SVB Leerink
Expect SVB Leerink revenue between $625-675M for FY'22
SVB Leerink expands our solutions for clients
Alternative
Equities
TOOLS &
DIAGNOSTICS
www
BIOPHARMA
Institutional
Equities
Convertible
Securities
LIFE SCIENCES/HEALTHCARE
svb >
Equity
MEDACorp Research
DIGITAL HEALTH
& HEALTHTECH
SVBLEERINK
Structured
Finance
HEALTHCARE
SERVICES
MEDICAL
DEVICES
SPACS
Equity
Capital
Markets
Private
Placements
DIGITAL
INFRA &
TECH SERVICES
បបប
M&A
Advisory
NEW TECHNOLOGY
Leveraged
Finance
CONSUMER
SOFTWARE,
INTERNET &
INFO SERVICES
EDUCATION
TECHNOLOGY مازل
FINTECH
INDUSTRIAL
TECHNOLOGY
ENTERPRISE
SOFTWARE
Q4'21 activity
• SVB Leerink continued to capitalize on strong public markets with
increased deal activity in the quarter: 18 book-run transactions in Q4
($3.5B in aggregate deal value)
●
Opportunistic hiring and addition of technology equity research added
$7M to Q4'21 SVB Leerink expenses
SVB LEERINK REVENUE¹
$ Millions
Commissions
Investment
Banking
SVB Leerink
expenses
151
18
133
166
24
142
120
17
103
107
17
SVB Leerink revenue outlook key assumptions:
90
FY'22 outlook key assumptions
1. Non-GAAP financial measure. See "Use of non-GAAP Financial Measures" in our Q4 2021 Earnings Release and our noRGAAP
reconciliations at the end of this presentation.
2. Included in FY'22 outlook for SVB Leerink revenue of $625M$675M.
Q4'20 Q1'21 Q2'21 Q3'21 Q4'21
$131M $136M $99M $142M $184M
145
21
124
New hires and expertise
Recent hires to grow technology, healthcare services and healthtech
investment banking expected to contribute $150-200M of revenues in
2022²; continue to add talent to deepen and expand capabilities
Strong public markets activity, but moderating from
FY'21's exceptional levels
Drives investment banking revenues
Strengthening collaboration
Between Commercial Bank and SVB Leerink, enhancedby "OneSVB"
initiative to deliver the full power of the SVB platform to clients
Note: Public market volatility could cause temporary pullbacks in deal
activity.
Q4 2021 Financial Highlights
34View entire presentation